日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy

SMYD3-SHCBP1的致癌激活促进乳腺癌的发生发展,并与免疫治疗耐药性相关。

Lihua Mo ,Min Deng ,Ragini Adhav ,Yuni Chan ,Josh Haipeng Lei ,Sek Man Su ,Xin Zhang ,Tingting An ,Jianlin Liu ,Jianjie Li ,Xiaodong Shu ,Jun Xu ,Yuqing Wang ,Lin Chen ,Yan-Gao Man ,Ning-Yi Shao ,Tingxiu Xiang ,Chu-Xia Deng ,Xiaoling Xu